Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-03

Clinical Trial Update: Protective Role of Vitamin D in Breast Cancer Patients Treated With Doxorubicin [Phase 2]

View source ↗

Summary

Phase 2 trial examining whether vitamin D provides a protective effect in breast cancer patients treated with doxorubicin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxorubicin (doxorubicin)
  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: Damanhour University | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED